61 related articles for article (PubMed ID: 24780097)
1. Anti-human immunodeficiency virus type 1 agent alpha-hydroxy glycineamide enters the target cells via a mechanism of passive diffusion.
Youssefi M; Vahlne A
J Pharm Pharmacol; 2014 Oct; 66(10):1388-93. PubMed ID: 24780097
[TBL] [Abstract][Full Text] [Related]
2. GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.
Jejcic A; Höglund S; Vahlne A
Retrovirology; 2010 Mar; 7():20. PubMed ID: 20230608
[TBL] [Abstract][Full Text] [Related]
3. Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide.
Andersson E; Horal P; Jejcic A; Höglund S; Balzarini J; Vahlne A; Svennerholm B
Antimicrob Agents Chemother; 2005 Jan; 49(1):40-4. PubMed ID: 15616273
[TBL] [Abstract][Full Text] [Related]
4. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.
Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934
[TBL] [Abstract][Full Text] [Related]
5. The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.
Su J; Andersson E; Horal P; Naghavi MH; Palm A; Wu YP; Eriksson K; Jansson M; Wigzell H; Svennerholm B; Vahlne A
J Hum Virol; 2001; 4(1):1-7. PubMed ID: 11213928
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology.
Abdurahman S; Végvári A; Levi M; Höglund S; Högberg M; Tong W; Romero I; Balzarini J; Vahlne A
Retrovirology; 2009 Apr; 6():34. PubMed ID: 19356241
[TBL] [Abstract][Full Text] [Related]
7. Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium.
Hubatsch I; Lazorova L; Vahlne A; Artursson P
Antimicrob Agents Chemother; 2005 Mar; 49(3):1087-92. PubMed ID: 15728907
[TBL] [Abstract][Full Text] [Related]
8. Hydroxy[14C]urea uptake by normal and transformed human cells: evidence for a mechanism of passive diffusion.
Tagger AY; Boux J; Wright JA
Biochem Cell Biol; 1987 Nov; 65(11):925-9. PubMed ID: 3442625
[TBL] [Abstract][Full Text] [Related]
9. Transport of amino acid amide sarcosinamide and sarcosinamide chloroethylnitrosourea in human glioma SK-MG-1 cells.
Skalski V; Feindel W; Panasci LC
Cancer Res; 1990 May; 50(10):3062-6. PubMed ID: 1692254
[TBL] [Abstract][Full Text] [Related]
10. Uptake of 2',3'-dideoxyadenosine in human immunodeficiency virus-infected and noninfected human cells.
Agarwal RP; Busso ME; Mian AM; Resnick L
AIDS Res Hum Retroviruses; 1989 Oct; 5(5):541-50. PubMed ID: 2590557
[TBL] [Abstract][Full Text] [Related]
11. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
[TBL] [Abstract][Full Text] [Related]
13. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
Misra A; Gleeson E; Wang W; Ye C; Zhou P; Kimata JT
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321330
[TBL] [Abstract][Full Text] [Related]
14. Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication.
Srinivas RV; Bernstein H; Oliver C; Compans RW
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1489-96. PubMed ID: 7888203
[TBL] [Abstract][Full Text] [Related]
15. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
16. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
[TBL] [Abstract][Full Text] [Related]
17. The proteinase inhibitor pepstatin A inhibits formation of reverse transcriptase in H9 cells infected with human immunodeficiency virus 1.
Grinde B; Hungnes O; Tjøtta E
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):269-74. PubMed ID: 2471542
[TBL] [Abstract][Full Text] [Related]
18. 3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes.
Purcet S; Minuesa G; Molina-Arcas M; Erkizia I; Casado FJ; Clotet B; Martinez-Picado J; Pastor-Anglada M
Antivir Ther; 2006; 11(6):803-11. PubMed ID: 17310825
[TBL] [Abstract][Full Text] [Related]
19. 3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
August EM; Birks EM; Prusoff WH
Mol Pharmacol; 1991 Feb; 39(2):246-9. PubMed ID: 1847498
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
